Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Showa University School of Medicine, Tokyo, Japan

Survival: 8.0 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: Japan
City/State/Province: Tokyo
Hospital: Showa University School of Medicine
Journal: Link
Date: 1/2003

Patients: This Phase I study involved 21 patients with advanced (stage IIIB or IV) non-small cell lung cancer. The average age of patients was 69.

Treatment: The treatment consisted of two drugs, gemcitabine and nedaplatin.

Toxicity: Grade 4 toxicities included neutropenia and thrombocytopenia. Other toxicities (grade 3 or less) included nausea/vomiting, diarrhea, elevation of transaminase, elevation of creatinine, and infection.

Results: Median survival time was 8.0 months.

Correspondence: T. Hirose, MD

E-mail to a Friend Email Physician More Information